We administered ICT (combined anti-PD-1 and anti-CTLA-4 monoclonal antibody treatment) to mice with or without B16-F10 melanoma tumors and assessed bacterial translocation by culturing mesenteric lymph node (MLN) homogenates on various selective media under anaerobic conditions (fig. This evidence concerns the gene CTLA4 and melanoma.